Literature DB >> 20172271

Natural history of intestinal failure induced by chronic idiopathic intestinal pseudo-obstruction.

V Stanghellini1, R F Cogliandro, R De Giorgio, G Barbara, C Cremon, A Antonucci, L Fronzoni, L Cogliandro, V Naponelli, M Serra, R Corinaldesi.   

Abstract

Chronic intestinal pseudo-obstruction is a severe, often unrecognized disease characterized by disabling and potentially life-threatening complications over time. The diagnosis is based on the evidence of typical clinical manifestations, radiological evidence of distended bowel loops with air-fluid levels, and the exclusion of any organic obstruction of the gut lumen. The radiological sign of intestinal occlusion allows the distinction from enteric dysmotility, which is characterized by better outcomes. Manometry can play a supportive role in defining the diagnosis, and differences in the manometric pattern of chronic intestinal pseudo-obstruction and enteric dysmotility have been shown. The disease is often unrecognized, and the diagnosis, therefore, delayed by several years. Thus, the majority of patients undergo useless and potentially dangerous surgeries. Long-term outcomes are generally poor despite surgical and medical therapies characterized by disabling and potentially life-threatening complications over time. A substantial percentage of patients requires parenteral nutrition. Failure of this nutritional support represents an indication for small bowel transplantation.

Entities:  

Mesh:

Year:  2010        PMID: 20172271     DOI: 10.1016/j.transproceed.2009.12.017

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  13 in total

1.  Management of gastrointestinal involvement in scleroderma.

Authors:  Vivek Nagaraja; Zsuzsanna H McMahan; Terri Getzug; Dinesh Khanna
Journal:  Curr Treatm Opt Rheumatol       Date:  2015-03-01

Review 2.  Gastroparesis: a turning point in understanding and treatment.

Authors:  Madhusudan Grover; Gianrico Farrugia; Vincenzo Stanghellini
Journal:  Gut       Date:  2019-09-28       Impact factor: 23.059

3.  Clinical importance of cine-MRI assessment of small bowel motility in patients with chronic intestinal pseudo-obstruction: a retrospective study of 33 patients.

Authors:  Akiko Fuyuki; Hidenori Ohkubo; Takuma Higurashi; Hiroshi Iida; Yumi Inoh; Masahiko Inamori; Atsushi Nakajima
Journal:  J Gastroenterol       Date:  2016-08-22       Impact factor: 7.527

Review 4.  Recent Advances in the Management of Severe Gastrointestinal Dysmotility.

Authors:  Dipesh H Vasant; Simon Lal
Journal:  Clin Exp Gastroenterol       Date:  2021-05-10

5.  Volvulus as a complication of chronic intestinal pseudo-obstruction syndrome.

Authors:  Carlijn T de Betue; Doeke Boersma; Matthijs W Oomen; Marc A Benninga; Justin R de Jong
Journal:  Eur J Pediatr       Date:  2011-09-23       Impact factor: 3.183

Review 6.  Intestinal manometry: who needs it?

Authors:  Gabrio Bassotti; Sara Bologna; Laura Ottaviani; Michele Russo; Maria Pina Dore
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2015

7.  Epidemiology and clinical experience of chronic intestinal pseudo-obstruction in Japan: a nationwide epidemiologic survey.

Authors:  Hiroshi Iida; Hidenori Ohkubo; Masahiko Inamori; Atsushi Nakajima; Hajime Sato
Journal:  J Epidemiol       Date:  2013       Impact factor: 3.211

8.  Molecular and Cellular Characteristics of the Colonic Pseudo-obstruction in Patients With Intractable Constipation.

Authors:  Yoon Suh Do; Seung-Jae Myung; Sun-Young Kwak; Soohan Cho; Enoch Lee; Min Jeong Song; Chang Sik Yu; Yong Sik Yoon; Hye Kyung Lee
Journal:  J Neurogastroenterol Motil       Date:  2015-10-01       Impact factor: 4.924

9.  Serial Frozen Fecal Microbiota Transplantation in the Treatment of Chronic Intestinal Pseudo-obstruction: A Preliminary Study.

Authors:  Lili Gu; Chao Ding; Hongliang Tian; Bo Yang; Xuelei Zhang; Yue Hua; Yifan Zhu; Jianfeng Gong; Weiming Zhu; Jieshou Li; Ning Li
Journal:  J Neurogastroenterol Motil       Date:  2017-04-30       Impact factor: 4.924

10.  GLP-2 Prevents Intestinal Mucosal Atrophy and Improves Tissue Antioxidant Capacity in a Mouse Model of Total Parenteral Nutrition.

Authors:  Qiucheng Lei; Jingcheng Bi; Xinying Wang; Tingting Jiang; Chao Wu; Feng Tian; Xuejin Gao; Xiao Wan; Huijun Zheng
Journal:  Nutrients       Date:  2016-01-09       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.